Replies to post #107721 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

NEW YORK — June 5, 2017 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, is scheduled to present on Friday, June 9, 2017, at 10:00 a.m. Eastern Daylight Time, at the Jefferies 2017 Global Healthcare Conference in New York City.

A live webcast including audio and slides and subsequent archived replay presentation can be accessed at http://wsw.com/webcast/jeff105/avxl or via the investor material page of the Company’s website at http://www.anavex.com/investors/investor-material/.

[nFUSZmywallet]

10, I wasn't able to watch or listen depending on video or just audio, but hopefully they have a replay